Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
- DOI
- 10.1136/bmjsit-2022-000152
- Published
- 2023-02
- Container
- BMJ Surgery, Interventions, & Health Technologies
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/bmjsit-2022-000152,
title = {Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018},
author = {Vinay K Rathi and James L Johnston and Sanket Dhruva and Joseph Ross},
year = {2023},
journal = {BMJ Surgery, Interventions, \& Health Technologies},
doi = {10.1136/bmjsit-2022-000152},
url = {https://doi.org/10.1136/bmjsit-2022-000152}
}RIS
TY - JOUR TI - Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018 AU - Vinay K Rathi AU - James L Johnston AU - Sanket Dhruva AU - Joseph Ross PY - 2023 JO - BMJ Surgery, Interventions, & Health Technologies DO - 10.1136/bmjsit-2022-000152 UR - https://doi.org/10.1136/bmjsit-2022-000152 ER -
APA
Rathi, V. K., Johnston, J. L., Dhruva, S., & Ross, J. (2023). Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018. BMJ Surgery, Interventions, & Health Technologies. https://doi.org/10.1136/bmjsit-2022-000152
Source records
- crossref · retrieved 2026-11-10T18:01:55.261Z